Cargando…
Mechanism‐Based Design of the First GlnA4‐Specific Inhibitors
γ‐Glutamylamine synthetases are an important class of enzymes that play a key role in glutamate‐based metabolism. Methionine sulfoximine (MSO) is a well‐established inhibitor for the archetypal glutamine synthetase (GS) but inhibitors for most GS‐like enzymes are unknown. Assuming a conserved cataly...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826267/ https://www.ncbi.nlm.nih.gov/pubmed/35976722 http://dx.doi.org/10.1002/cbic.202200312 |
_version_ | 1784866810117488640 |
---|---|
author | Purder, Patrick L. Meyners, Christian Krysenko, Sergii Funk, Jonathan Wohlleben, Wolfgang Hausch, Felix |
author_facet | Purder, Patrick L. Meyners, Christian Krysenko, Sergii Funk, Jonathan Wohlleben, Wolfgang Hausch, Felix |
author_sort | Purder, Patrick L. |
collection | PubMed |
description | γ‐Glutamylamine synthetases are an important class of enzymes that play a key role in glutamate‐based metabolism. Methionine sulfoximine (MSO) is a well‐established inhibitor for the archetypal glutamine synthetase (GS) but inhibitors for most GS‐like enzymes are unknown. Assuming a conserved catalytic mechanism for GS and GS‐like enzymes, we explored if subtype‐selective inhibitors can be obtained by merging MSO with the cognate substrates of the respective GS‐like enzymes. Using GlnA4( Sc ) from Streptomyces coelicolor, an enzyme recently shown to produce γ‐glutamylethanolamine, we demonstrate that MSO can be reengineered in a straightforward fashion into potent and selective GlnA4( Sc ) inhibitors. Linkage chemistry as well as linker length between the MSO moiety and the terminal hydroxyl group derived from ethanolamine were in agreement with the postulated phosphorylated catalytic intermediate. The best GlnA4 inhibitor 7 b potently blocked S. coelicolor growth in the presence of ethanolamine as the sole nitrogen source. Our results provide the first GlnA4( Sc )‐specific inhibitors and suggest a general strategy to develop mechanism‐based inhibitors for GS‐like enzymes. |
format | Online Article Text |
id | pubmed-9826267 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98262672023-01-09 Mechanism‐Based Design of the First GlnA4‐Specific Inhibitors Purder, Patrick L. Meyners, Christian Krysenko, Sergii Funk, Jonathan Wohlleben, Wolfgang Hausch, Felix Chembiochem Research Articles γ‐Glutamylamine synthetases are an important class of enzymes that play a key role in glutamate‐based metabolism. Methionine sulfoximine (MSO) is a well‐established inhibitor for the archetypal glutamine synthetase (GS) but inhibitors for most GS‐like enzymes are unknown. Assuming a conserved catalytic mechanism for GS and GS‐like enzymes, we explored if subtype‐selective inhibitors can be obtained by merging MSO with the cognate substrates of the respective GS‐like enzymes. Using GlnA4( Sc ) from Streptomyces coelicolor, an enzyme recently shown to produce γ‐glutamylethanolamine, we demonstrate that MSO can be reengineered in a straightforward fashion into potent and selective GlnA4( Sc ) inhibitors. Linkage chemistry as well as linker length between the MSO moiety and the terminal hydroxyl group derived from ethanolamine were in agreement with the postulated phosphorylated catalytic intermediate. The best GlnA4 inhibitor 7 b potently blocked S. coelicolor growth in the presence of ethanolamine as the sole nitrogen source. Our results provide the first GlnA4( Sc )‐specific inhibitors and suggest a general strategy to develop mechanism‐based inhibitors for GS‐like enzymes. John Wiley and Sons Inc. 2022-09-06 2022-10-06 /pmc/articles/PMC9826267/ /pubmed/35976722 http://dx.doi.org/10.1002/cbic.202200312 Text en © 2022 The Authors. ChemBioChem published by Wiley-VCH GmbH https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Research Articles Purder, Patrick L. Meyners, Christian Krysenko, Sergii Funk, Jonathan Wohlleben, Wolfgang Hausch, Felix Mechanism‐Based Design of the First GlnA4‐Specific Inhibitors |
title | Mechanism‐Based Design of the First GlnA4‐Specific Inhibitors |
title_full | Mechanism‐Based Design of the First GlnA4‐Specific Inhibitors |
title_fullStr | Mechanism‐Based Design of the First GlnA4‐Specific Inhibitors |
title_full_unstemmed | Mechanism‐Based Design of the First GlnA4‐Specific Inhibitors |
title_short | Mechanism‐Based Design of the First GlnA4‐Specific Inhibitors |
title_sort | mechanism‐based design of the first glna4‐specific inhibitors |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826267/ https://www.ncbi.nlm.nih.gov/pubmed/35976722 http://dx.doi.org/10.1002/cbic.202200312 |
work_keys_str_mv | AT purderpatrickl mechanismbaseddesignofthefirstglna4specificinhibitors AT meynerschristian mechanismbaseddesignofthefirstglna4specificinhibitors AT krysenkosergii mechanismbaseddesignofthefirstglna4specificinhibitors AT funkjonathan mechanismbaseddesignofthefirstglna4specificinhibitors AT wohllebenwolfgang mechanismbaseddesignofthefirstglna4specificinhibitors AT hauschfelix mechanismbaseddesignofthefirstglna4specificinhibitors |